U.S. Companies Are Leading Bidders in British Health Service Sell-Off
Cancer and end-of-life services relied on by some 3.8 million beneficiaries of the British National Health Service may be sold off to private U.S. health care companies that will be free to restructure the services along lines of profitability rather than quality of care.
A leaked memo cited by a parliamentary candidate for the U.K. Labour Party details an effort to sell off cancer and end-of-life services relied on by some 3.8 million beneficiaries of the British National Health Service to private U.S. health care companies that will be free to restructure the services along lines of profitability rather than quality of care.
“There are lots of firsts here,” candidate Kate Godfrey, who received the confidential documents, writes at The Guardian:
It is the first time that cancer or end-of-life care has been contracted out. The first use of the prime provider model on anything like this scale. The first privatisation without formal consultation. The first huge international NHS contract that could fall under TTIP. Transfer these services out of the NHS now, and we may never get them back.
The leading bidders are all US private healthcare companies, some of them implicated in failures of care elsewhere. One is Optum, the US brand facing allegations over the American hospice-packing scandal. (Optum is defending itself against the allegations.) It is the first time that the commissioning responsibility held by local clinical commissioning groups (CCGs) – the right to spend a billion pounds on behalf of the NHS – will simply be gifted to a private company. …
The winning bidder will be free to decommission or disinvest as they like – cutting contracts with local hospices, therapeutic providers or even frontline healthcare such as radiotherapy and surgery.
The bidder could simply replace them, delivering services such as radiotherapy themselves, further fragmenting the services that mean most to patients. Or they could just squeeze existing contracts. No payment structure is specified. Bidding companies can decide for themselves what they are worth, as long as their fees are self-funding within the current budget. Based on similar health privatisation contracts, £100m in fees is the minimum that a private provider will accept. This money will be diverted straight from funds currently spent on frontline care.
Read more here.
— Posted by Alexander Reed Kelly.
Your support is crucial...As we navigate an uncertain 2025, with a new administration questioning press freedoms, the risks are clear: our ability to report freely is under threat.
Your tax-deductible donation enables us to dig deeper, delivering fearless investigative reporting and analysis that exposes the reality behind the headlines — without compromise.
Now is the time to take action. Stand with our courageous journalists. Donate today to protect a free press, uphold democracy and uncover the stories that need to be told.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.